Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

dc.contributor.author	Mandel, Nil
dc.contributor.author	Yildiz, Ozcan
dc.contributor.author	Yanmaz, Teoman
dc.contributor.author	Serdengecti, Suheyla
dc.contributor.author	Ozguroglu, Mustafa
dc.contributor.author	Evrensel, Turkkan
dc.contributor.author	Er, Ozlem
dc.contributor.author	Turna, Hande
dc.date.accessioned	2021-03-06T12:27:06Z
dc.date.available	2021-03-06T12:27:06Z
dc.identifier.citation	Ozguroglu M., Evrensel T., Er O., Turna H., Yanmaz T., Yildiz O., Mandel N., Serdengecti S., "Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)", 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.225
dc.identifier.other	vv_1032021
dc.identifier.other	av_f3e64777-3682-42b1-9eb4-c5961984e9fb
dc.identifier.uri	http://hdl.handle.net/20.500.12627/159923
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	17
dc.contributor.firstauthorID	131691

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.